androstane-3,17-diol has been researched along with Hypergonadotropic Hypogonadism in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (85.71) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cobey, K; Coelingh Bennink, HJ; Fauser, BC; Foidart, JM; Minon, JM; Pintiaux, A; Zimmerman, Y | 1 |
Anderson, DC; Cantrill, JA; Dewis, P; Large, DM; Newman, M | 1 |
Stahl, F | 1 |
Bundschu, HD; Hayduk, K; Heller, S; Liebau, G; Lüders, G; Pfeiffer, EH; Rager, K | 1 |
Dolman, LI; Lagerquist, LG; Meikle, AW; Stringham, JD; Tyler, FH | 1 |
O'Shaughnessy, PJ; Sheffield, JW | 1 |
Ahmed, SR; Bartholomew, M; Boucher, AE; Demers, LM; Manni, A; Santen, RJ | 1 |
1 review(s) available for androstane-3,17-diol and Hypergonadotropic Hypogonadism
Article | Year |
---|---|
[The determination, secretion and plasma concentration of androgens].
Topics: Adolescent; Adult; Age Factors; Androgen Antagonists; Androgen-Binding Protein; Androgens; Androstane-3,17-diol; Androstenedione; Child; Dehydroepiandrosterone; Dihydrotestosterone; Female; Humans; Hypogonadism; Infant; Male; Pregnancy; Radioimmunoassay; Sex Factors; Testosterone; Virilism | 1979 |
1 trial(s) available for androstane-3,17-diol and Hypergonadotropic Hypogonadism
Article | Year |
---|---|
Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.
Topics: Adolescent; Adult; Androgen Antagonists; Androstane-3,17-diol; Androstenedione; Androstenes; Belgium; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypogonadism; Sex Hormone-Binding Globulin; Solubility; Testosterone; Up-Regulation; Young Adult | 2015 |
5 other study(ies) available for androstane-3,17-diol and Hypergonadotropic Hypogonadism
Article | Year |
---|---|
Which testosterone replacement therapy?
Topics: Administration, Oral; Adult; Aged; Androstane-3,17-diol; Dihydrotestosterone; Drug Implants; Estradiol; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Testosterone | 1984 |
[Effects of longterm HCG administration on testicular function in hemodialysis patients (author's transl)].
Topics: Adult; Androstane-3,17-diol; Cell Count; Chorionic Gonadotropin; Dihydrotestosterone; Follicle Stimulating Hormone; Humans; Hypogonadism; Kidney Failure, Chronic; Long-Term Care; Luteinizing Hormone; Male; Middle Aged; Renal Dialysis; Spermatozoa; Testosterone | 1976 |
Plasma 5alpha androstanediol: an androgen marker of hirsuitism in women.
Topics: Adolescent; Adult; Androstane-3,17-diol; Androstanes; Dexamethasone; Diethylstilbestrol; Estradiol Congeners; Female; Hirsutism; Humans; Hypogonadism; Male; Progestins; Testosterone | 1976 |
Effect of injection of gonadotrophin-releasing hormone on testicular steroidogenesis in the hypogonadal (hpg) mouse.
Topics: Androgens; Androstane-3,17-diol; Androstenedione; Animals; Hypogonadism; Male; Mice; Mice, Mutant Strains; Pituitary Hormone-Releasing Hormones; Testis; Testosterone | 1989 |
Transdermal testosterone therapy in the treatment of male hypogonadism.
Topics: Administration, Cutaneous; Androstane-3,17-diol; Dihydrotestosterone; Estradiol; Humans; Hypogonadism; Male; Testosterone | 1988 |